Related Experiment Video

Updated: Jul 7, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

[Treatment of stroke in patients with and without diabetes--similarity and differences]

Marek Zalisz1

  • 1Samodzielny Publiczny Zakład Opieki Zdrowotnej Działdowo, Oddział Neurologii z Pododdziałem Udarowym. neurologiadz@o2.pl

Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego
|February 26, 2008
PubMed

Insights

Diabetic patients increasingly experience strokes, necessitating careful blood glucose monitoring and tailored therapies. Prevention strategies emphasize optimizing blood sugar, blood pressure, and lipid levels, with potential benefits from clopidogrel over aspirin for secondary prevention.

Area of Science:

  • Neurology
  • Endocrinology
  • Cardiovascular Medicine

Context:

  • Rising prevalence of diabetes mellitus contributes to increased stroke incidence.
  • Neurologists encounter a growing number of diabetic patients experiencing strokes.
  • Diabetes management significantly impacts stroke morbidity and outcomes.

Purpose:

  • To outline the specific considerations for managing acute stroke in diabetic patients.
  • To detail primary and secondary stroke prevention strategies in individuals with diabetes.
  • To highlight differences in therapeutic targets for hypertension and dyslipidemia in diabetic stroke patients.

Summary:

  • Acute stroke management in diabetic patients requires precise blood glucose monitoring and intensive insulin therapy.
  • Contraindications to thrombolysis must be carefully assessed in diabetic patients.
  • Primary and secondary stroke prevention involves optimizing glycemic control, lowering hypertension and lipid levels more aggressively than in non-diabetic populations.
  • Evidence suggests clopidogrel may offer greater benefits than aspirin for secondary stroke prevention in diabetics.

Impact:

  • Improved clinical outcomes for diabetic stroke patients through tailored acute management and prevention.
  • Enhanced understanding of risk factor modification in this high-risk population.
  • Potential shift in secondary prevention guidelines, favoring specific antiplatelet agents for diabetic patients.

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Stroke: Introduction and Types01:29

Stroke: Introduction and Types

A stroke is an acute neurological event caused by the sudden disruption of cerebral blood flow, leading to rapid loss of neuronal function. Neurons depend on continuous oxygen and glucose supply, so even brief interruptions can cause irreversible injury within minutes. Strokes are classified into ischemic and hemorrhagic types.Ischemic StrokeIschemic strokes are most common and occur due to arterial occlusion, depriving brain tissue of oxygen and nutrients. This leads to energy failure, ionic...
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...